Commodore Capital as of March 31, 2022
Portfolio Holdings for Commodore Capital
Commodore Capital holds 27 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 10.7 | $48M | 1.8M | 26.44 | |
| Aclaris Therapeutics (ACRS) | 8.9 | $40M | 2.3M | 17.24 | |
| Bellus Health Com New | 8.7 | $39M | 5.6M | 6.88 | |
| Iveric Bio | 8.3 | $37M | 2.2M | 16.83 | |
| Xenon Pharmaceuticals (XENE) | 8.2 | $37M | 1.2M | 30.57 | |
| Cytokinetics Com New (CYTK) | 7.0 | $32M | 855k | 36.81 | |
| Karyopharm Therapeutics | 5.9 | $26M | 3.6M | 7.37 | |
| Cogent Biosciences (COGT) | 5.9 | $26M | 3.5M | 7.49 | |
| Cymabay Therapeutics | 4.0 | $18M | 5.7M | 3.11 | |
| Miragen Therapeutics (VRDN) | 3.9 | $18M | 951k | 18.49 | |
| Tricida | 3.2 | $14M | 1.7M | 8.22 | |
| Satsuma Pharmaceuticals Ord | 3.1 | $14M | 3.7M | 3.80 | |
| Vistagen Therapeutics Com New | 2.8 | $13M | 10M | 1.24 | |
| Kura Oncology (KURA) | 2.8 | $13M | 777k | 16.08 | |
| C4 Therapeutics Com Stk (CCCC) | 2.6 | $12M | 481k | 24.26 | |
| Immunic (IMUX) | 2.3 | $10M | 893k | 11.30 | |
| Celcuity (CELC) | 1.9 | $8.6M | 921k | 9.35 | |
| Celldex Therapeutics Com New (CLDX) | 1.8 | $8.2M | 241k | 34.06 | |
| Protagonist Therapeutics (PTGX) | 1.8 | $7.9M | 332k | 23.68 | |
| Tenaya Therapeutics (TNYA) | 1.4 | $6.1M | 514k | 11.78 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $4.6M | 313k | 14.74 | |
| Genocea Biosciences Com New (GNCAQ) | 0.9 | $3.9M | 3.1M | 1.25 | |
| Inventiva Sa Ads (IVA) | 0.7 | $3.0M | 263k | 11.40 | |
| Dyne Therapeutics (DYN) | 0.7 | $2.9M | 305k | 9.64 | |
| Pmv Pharmaceuticals (PMVP) | 0.6 | $2.6M | 125k | 20.82 | |
| Bcls Acquisition Corp Com Cl A | 0.6 | $2.5M | 250k | 9.87 | |
| Mereo Biopharma Group Ads (MREO) | 0.5 | $2.2M | 2.0M | 1.12 |
